Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Taguri

Showing results (281-290 of 330) with videos related to

Pageof 33
Sort By:
Trials|June 4, 2020
Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET studyAnna Ozaki, Takaomi Kessoku, Michihiro Iwaki, et al.
Annals of Medicine|January 17, 2025
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional studyYoshiaki Takada, Hiroki Kiyohara, Yohei Mikami, et al.
Journal of Pharmacological Sciences|August 7, 2017
The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicityMasanari Umemura, Jeong-Hwan Kim, Haruki Aoyama, et al.
The Lancet. Oncology|March 8, 2016
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trialTakuma Higurashi, Kunihiro Hosono, Hirokazu Takahashi, et al.
BMC Cancer|June 3, 2014
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organManabu Kakizoe, Masahiro Yao, Ukihide Tateishi, et al.
JACC. Cardiovascular Interventions|April 21, 2018
Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI RegistryMasaki Miyasaka, Norio Tada, Masataka Taguri, et al.
JMA Journal|December 16, 2020
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with PembrolizumabJun Sugisaka, Yukihiro Toi, Masataka Taguri, et al.
Clinical and Translational Gastroenterology|August 24, 2022
Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled TrialYohei Kamata, Takaomi Kessoku, Tomoko Shimizu, et al.
Arthritis Research & Therapy|June 6, 2019
Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet's diseaseNaomi Tsuchida, Yohei Kirino, Yutaro Soejima, et al.
Journal of Hepatology|March 1, 2015
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaNaoto Fujiwara, Hayato Nakagawa, Yotaro Kudo, et al.
Pageof 33

Showing results (281-290 of 330) with videos related to

Sort By:
Pageof 33
Trials|June 4, 2020
Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET studyAnna Ozaki, Takaomi Kessoku, Michihiro Iwaki, et al.
Annals of Medicine|January 17, 2025
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional studyYoshiaki Takada, Hiroki Kiyohara, Yohei Mikami, et al.
Journal of Pharmacological Sciences|August 7, 2017
The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicityMasanari Umemura, Jeong-Hwan Kim, Haruki Aoyama, et al.
The Lancet. Oncology|March 8, 2016
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trialTakuma Higurashi, Kunihiro Hosono, Hirokazu Takahashi, et al.
BMC Cancer|June 3, 2014
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organManabu Kakizoe, Masahiro Yao, Ukihide Tateishi, et al.
JACC. Cardiovascular Interventions|April 21, 2018
Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI RegistryMasaki Miyasaka, Norio Tada, Masataka Taguri, et al.
JMA Journal|December 16, 2020
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with PembrolizumabJun Sugisaka, Yukihiro Toi, Masataka Taguri, et al.
Clinical and Translational Gastroenterology|August 24, 2022
Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled TrialYohei Kamata, Takaomi Kessoku, Tomoko Shimizu, et al.
Arthritis Research & Therapy|June 6, 2019
Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet's diseaseNaomi Tsuchida, Yohei Kirino, Yutaro Soejima, et al.
Journal of Hepatology|March 1, 2015
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaNaoto Fujiwara, Hayato Nakagawa, Yotaro Kudo, et al.
Pageof 33